Your session is about to expire
← Back to Search
Inflatable Penile Prosthesis for Erectile Dysfunction
Study Summary
This trial looks at the long-term safety and effectiveness of a penile prosthesis for erectile dysfunction over 3 years. Patients are monitored after implantation to see how they respond to the prosthesis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a bleeding disorder that may make procedures unsafe for me.I have been diagnosed with a fibrotic condition affecting my reproductive organs.You are willing to complete all protocol required follow-up visits and tests.I have been diagnosed with reduced sensation in my penis.I have a compromised immune system due to conditions like lupus or scleroderma.I am a man aged 21 or older.I have had surgery for penile prosthesis or enlargement before.I do not have any active infections, especially in the area where surgery is planned.I do not have any major health issues that could affect the study's safety or results.I have been diagnosed with erectile dysfunction.My fasting blood sugar is not over 300 on the morning of surgery.I can communicate clearly and understand the study's requirements.I agree to use Infla10® three-piece IPP for erectile dysfunction treatment.I cannot have general anesthesia due to health risks.I agree to use Infla10® as treatment for erectile dysfunction.I am a man aged 21 or older.I have been diagnosed with erectile dysfunction.
- Group 1: Experimental: Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any slots available for this experiment that are open to participants?
"Affirmative. The details posted on clinicaltrials.gov demonstrate that this medical experiment is currently enrolling patients. Initially launched on July 11th 2022, the trial requires 177 participants to be recruited from a single centre."
Who has the opportunity to join this medical experiment?
"This research is recruiting 177 volunteers between the ages of 21-90 with erectile dysfunction who meet additional criteria, such as being male and agreeing to receive a three-piece IPP for treatment. Participants must also commit to complete all necessary follow ups visits and tests required by the protocol."
How many subjects are participating in this research endeavor?
"Affirmative. Clinicaltrials.gov illustrates that this experiment, first published on July 11th 2022, is recruiting participants at the moment. An estimated 177 individuals are needed to be acquired from one single centre for research purposes."
Is this research open to participants over the age of thirty?
"The minimum age requirement for enrolment in this medical trial is 21 years old, with the maximum age set at 90."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger